Adagio Medical Holdings (ADGM) Change in Accured Expenses (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Change in Accured Expenses data on file, last reported at $135000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 123.4% year-over-year to $135000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.6 million (down 728.33% YoY), and the FY2025 full-year result was $3.3 million, up 2498.43% from the prior year.
• Change in Accured Expenses advanced to $135000.0 in Q1 2026, from -$1.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $963000.0 in Q2 2024 to a low of -$1.5 million in Q4 2025.
• A 4-year average of -$167142.9 and a median of -$216000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses sank 185.1% in 2025 and soared 123.4% in 2026, its largest moves.
• Tracing ADGM's Change in Accured Expenses over 4 years: stood at -$216000.0 in 2023, then plunged by 201.39% to -$651000.0 in 2024, then plunged by 130.72% to -$1.5 million in 2025, then jumped by 108.99% to $135000.0 in 2026.
• Business Quant data shows ADGM's Change in Accured Expenses at $135000.0 in Q1 2026, -$1.5 million in Q4 2025, and -$577000.0 in Q1 2025.